proposed that targeting STAT3 can inhibit tumor growth through downregulating Bcl‐xL expression to increase apoptosis of HNSCC cancer cells, which supports the view of STAT3 as an oncogene.45 This evidence concerns the gene STAT3 and head and neck squamous cell carcinoma.